Patents by Inventor Sandeep Kumar VATS

Sandeep Kumar VATS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTENDED RELEASE LIQUID COMPOSITIONS OF GUAIFENESIN
    Publication number: 20230172875
    Abstract: The present invention relates to extended release liquid compositions of guaifenesin. The extended release liquid compositions are in the form of suspensions which are ready-to-use or suspensions which are reconstituted from powder. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Application
    Filed: January 30, 2023
    Publication date: June 8, 2023
    Inventors: Radhakrishna VANKAYALA, Balaram MONDAL, Sandeep Kumar VATS, Kalaiselvan RAMARAJU, Romi Barat SINGH, Ashish KUMAR
  • EXTENDED RELEASE LIQUID COMPOSITIONS OF GUAIFENESIN
    Publication number: 20190046468
    Abstract: The present invention relates to extended release liquid compositions of guaifenesin. The extended release liquid compositions are in the form of suspensions which are ready-to-use or suspensions which are reconstituted from powder. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Application
    Filed: August 13, 2018
    Publication date: February 14, 2019
    Inventors: Radhakrishna VANKAYALA, Balaram MONDAL, Sandeep Kumar VATS, Kalaiselvan RAMARAJU, Romi Barat SINGH, Ashish KUMAR
  • CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE
    Publication number: 20170340583
    Abstract: This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed Toprol-XL® tablet. The extended-release capsule dosage form comprising coated discrete units can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules.
    Type: Application
    Filed: August 21, 2017
    Publication date: November 30, 2017
    Inventors: Sandeep Kumar VATS, Balaram MONDAL, Kalaiselvan RAMARAJU, Romi Barat SINGH
  • Dissolution enhanced controlled drug delivery system for poorly water soluble drugs
    Patent number: 9750696
    Abstract: The present invention relates to controlled-release pharmaceutical dosage forms comprising a solid dispersion of a poorly water-soluble or insoluble drug with improved solubility and thus improved dissolution in an aqueous medium. The invention further discloses a process of preparation of these controlled-release dosage forms.
    Type: Grant
    Filed: August 1, 2012
    Date of Patent: September 5, 2017
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Sandeep Kumar Vats, Kalaiselvan Ramaraju, Romi Barat Singh
  • Capsule dosage form of metoprolol succinate
    Patent number: 9700530
    Abstract: This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed Toprol-XL® tablet. The extended-release capsule dosage form comprising coated discrete units can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: July 11, 2017
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Sandeep Kumar Vats, Balaram Mondal, Kalaiselvan Ramaraju, Romi Barat Singh
  • CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE
    Publication number: 20170189351
    Abstract: This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed Toprol-XL® tablet. The extended-release capsule dosage form comprising coated discrete units can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules.
    Type: Application
    Filed: March 22, 2017
    Publication date: July 6, 2017
    Inventors: Sandeep Kumar VATS, Balaram MONDAL, Kalaiselvan RAMARAJU, Romi Barat SINGH
  • SUSTAINED RELEASE ORAL PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB
    Publication number: 20170049774
    Abstract: The present invention relates to sustained release oral pharmaceutical compositions of tofacitinib comprising tofacitinib, a release controlling polymer, and pharmaceutically acceptable excipients, wherein the sustained release oral pharmaceutical compositions further comprise an outer modified release coating that includes a modified release polymer. The invention also relates to a process for the preparation of the compositions.
    Type: Application
    Filed: August 10, 2016
    Publication date: February 23, 2017
    Inventors: Romi Barat SINGH, Kalaiselvan RAMARAJU, Sandeep Kumar VATS, Pulak Kumar METIA, Balamurali Krishna NOOKA
  • CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE
    Publication number: 20170042837
    Abstract: This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed ToprolXL® tablet. The extended-release capsule dosage form comprising coated discrete units can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules.
    Type: Application
    Filed: October 28, 2016
    Publication date: February 16, 2017
    Inventors: Sandeep Kumar VATS, Balaram MONDAL, Kalaiselvan RAMARAJU, Romi Barat SINGH
  • Capsule dosage form of metoprolol succinate
    Patent number: 9504655
    Abstract: The present invention provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units and processes for their preparation.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: November 29, 2016
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Sandeep Kumar Vats, Balaram Mondal, Kalaiselvan Ramaraju, Romi Barat Singh
  • CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE
    Publication number: 20160143856
    Abstract: The present invention provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units and processes for their preparation.
    Type: Application
    Filed: February 1, 2016
    Publication date: May 26, 2016
    Inventors: Sandeep Kumar VATS, Balaram MONDAL, Kalaiselvan RAMARAJU, Romi Barat SINGH
  • EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS OF METOPROLOL
    Publication number: 20160143864
    Abstract: The present invention relates to timed extended-release pharmaceutical compositions comprising metoprolol and an extended-release polymer. The pharmaceutical compositions of the present invention exhibit an in-vivo lag time of at least 2 hours as and a Tmax of more than 8 hours. Further, said pharmaceutical compositions provide an in-vitro release of metoprolol over a period of at least 20 hours.
    Type: Application
    Filed: July 9, 2014
    Publication date: May 26, 2016
    Inventors: Sandeep Kumar VATS, Balaram MONDAL, Kalaiselvan RAMARAJU, Romi Barat SINGH, Ajay Kumar SINGLA
  • DISSOLUTION ENHANCED CONTROLLED DRUG DELIVERY SYSTEM FOR POORLY WATER SOLUBLE DRUGS
    Publication number: 20150174071
    Abstract: The present invention relates to controlled-release pharmaceutical dosage forms comprising a solid dispersion of a poorly water-soluble or insoluble drug with improved solubility and thus improved dissolution in an aqueous medium. The invention further discloses a process of preparation of these controlled-release dosage forms.
    Type: Application
    Filed: August 1, 2012
    Publication date: June 25, 2015
    Applicant: Ranbaxy Laboratories Limited
    Inventors: Sandeep Kumar Vats, Kalaiselvan Ramaraju, Romi Barat Singh
  • PHARMACEUTICAL COMPOSITIONS CONTAINING A BIGUANIDE AND A LOW DOSE ANTIDIABETIC AGENT
    Publication number: 20130251795
    Abstract: The present invention relates to pharmaceutical compositions that include a combination of a biguanide present in an extended-release form and a low dose antidiabetic agent present in an immediate-release form. The present invention further relates to processes for preparing such compositions.
    Type: Application
    Filed: May 13, 2013
    Publication date: September 26, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sandeep Kumar VATS, Balaram MONDAL, Kalaiselvan RAMARAJU, Romi Barat SINGH, Ajay Kumar SINGLA
  • PHARMACEUTICAL COMPOSITIONS CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE
    Publication number: 20120093878
    Abstract: The present invention relates to pharmaceutical compositions that include a combination of a biguanide present in an extended-release form and a thiazolidinedione present in an immediate-release form. The present invention further relates to the processes for preparing such compositions.
    Type: Application
    Filed: July 29, 2011
    Publication date: April 19, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Romi Barat SINGH, Kalaiselvan RAMARAJU, Sandeep Kumar VATS, Balaram MONDAL